Biocon earnings Biocon posts 9% operating revenue growth in Q3 FY26; EBITDA margin at 22% 6 hours ago Biocon Limited (BSE: 532523 / NSE: BIOCON) reported consolidated operating revenue growth of 9% year-on-year for the quarter ended December…